Iperion Ltd
IPR
Company Profile
Business description
Iperion Ltd is engaged in the process of commercializing a novel antimicrobial coating product, being marketed under the name Pathoglaze. The company is engaged in manufacturing, selling, distributing, importing, and exporting a self-cleaning, transparent, antimicrobial surface coating product.
Contact
c/o Duncan Cotterill
50 Customhouse Quay
Level 5 Tower Building
WellingtonNTL6011
NZLT: +64 272428485
Sector
Financial Services
Stock type
Cyclical
Industry
Shell Companies
Fiscal Year End
31 March 2026
Employees
Stocks News & Analysis
stocks
Wildly overvalued ASX stock is skating on thin ice
This company dominates its industry and could be flirting with regulatory intervention.
stocks
Uber flexes its network effect and delivers strong result
Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.
stocks
Ask the analyst: Are Qantas shares a value trap?
Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,088.70 | 22.40 | -0.25% |
| CAC 40 | 7,635.03 | 13.99 | 0.18% |
| DAX 40 | 23,924.36 | 78.29 | 0.33% |
| Dow JONES (US) | 44,193.12 | 81.38 | 0.18% |
| FTSE 100 | 9,164.31 | 21.58 | 0.24% |
| HKSE | 25,018.97 | 108.34 | 0.43% |
| NASDAQ | 21,169.42 | 252.87 | 1.21% |
| Nikkei 225 | 41,081.22 | 286.36 | 0.70% |
| NZX 50 Index | 12,922.20 | 42.04 | 0.33% |
| S&P 500 | 6,345.06 | 45.87 | 0.73% |
| S&P/ASX 200 | 8,819.20 | 24.50 | -0.28% |
| SSE Composite Index | 3,638.40 | 4.40 | 0.12% |